Research Progress on the Treatment of COPD with Suzi Jiangqi Decoction Combined with Sanzi Yangqin Decoction

目的:慢性阻塞性肺疾病(COPD)是全球范围内导致高发病率和高死亡率的重要疾病,并对社会经济造成严重负担。本研究旨在评估苏子降气汤联合三子养亲汤在COPD治疗中的临床应用及疗效,特别是其对痰浊阻肺证的治疗作用。方法:对近年的临床研究和实验数据进行回顾分析,评估苏子降气汤合三子养亲汤在COPD治疗中的效果。结果:临床试验表明,该方剂联合治疗可显著缓解COPD患者的咳嗽、喘息和气短等症状,同时改善肺功能指标,且不良反应较少。此外,该组合治疗可提高患者的生活质量,改善呼吸健康状况。结论:苏子降气汤合三子养亲汤在COPD治疗中具有良好的临床疗效,特别适用于痰浊阻肺证的管理。现有证据支持其在改善肺功能和缓解症状方面的有效性,并可能相较于传统治疗方案提供额外优势。然而,仍需进一步开展大规模、随机对照试验,以进一步验证其长期安全性和疗效。Objective: Chronic obstructive pulmonary disease (COPD) is a major global health burden, characterized by high morbidity and mortality rates, and imposing significant socioeconomic challenges. This study aims to evaluate the clinical application and therapeutic efficacy of Suzi Jiangqi Decoction combined with Sanzi Yangqin Decoction in the treatment of COPD, with a particular focus on its role in managing phlegm-damp obstruction of the lungs. Methods: A comprehensive review of recent clinical studies and experimental data was conducted to assess the therapeutic effects of Suzi Jiangqi Decoction and Sanzi Yangqin Decoction in COPD management. The analysis focused on their impact on pulmonary function, symptom relief, and potential mechanisms of action. Results: Clinical trials have shown that this combined prescription can significantly alleviate symptoms such as cough, wheezing, and shortness of breath in patients with COPD, while also improving pulmonary function indicators, with fewer adverse reactions. In addition, the combination therapy can enhance patients’ quality of life and improve respiratory health status. Conclusion: The combination of Suzi Jiangqi Decoction and Sanzi Yangqin Decoction demonstrates promising clinical efficacy in the treatment of COPD, particularly for phlegm-damp obstruction of the lungs. Current evidence supports its therapeutic benefits in improving lung function and alleviating symptoms, potentially offering advantages over conventional treatments. However, further large-scale, randomized controlled trials (RCTs) are essential to validate its long-term safety and effectiveness.

Authors

Publication Details

Journal
Advances in Clinical Medicine
Published
2025-01-01
DOI
https://doi.org/10.12677/acm.2025.1551478
Primary Topic
Chronic Obstructive Pulmonary Disease (COPD) Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Research Progress on the Treatment of COPD with Suzi Jiangqi Decoction Combined with Sanzi Yangqin Decoction

健航 任
Advances in Clinical Medicine
Chronic Obstructive Pulmonary Disease (COPD) Research
article

Research Progress on the Treatment of COPD with Suzi Jiangqi Decoction Combined with Sanzi Yangqin Decoction

健航 任
article en

Abstract

目的:慢性阻塞性肺疾病(COPD)是全球范围内导致高发病率和高死亡率的重要疾病,并对社会经济造成严重负担。本研究旨在评估苏子降气汤联合三子养亲汤在COPD治疗中的临床应用及疗效,特别是其对痰浊阻肺证的治疗作用。方法:对近年的临床研究和实验数据进行回顾分析,评估苏子降气汤合三子养亲汤在COPD治疗中的效果。结果:临床试验表明,该方剂联合治疗可显著缓解COPD患者的咳嗽、喘息和气短等症状,同时改善肺功能指标,且不良反应较少。此外,该组合治疗可提高患者的生活质量,改善呼吸健康状况。结论:苏子降气汤合三子养亲汤在COPD治疗中具有良好的临床疗效,特别适用于痰浊阻肺证的管理。现有证据支持其在改善肺功能和缓解症状方面的有效性,并可能相较于传统治疗方案提供额外优势。然而,仍需进一步开展大规模、随机对照试验,以进一步验证其长期安全性和疗效。Objective: Chronic obstructive pulmonary disease (COPD) is a major global health burden, characterized by high morbidity and mortality rates, and imposing significant socioeconomic challenges. This study aims to evaluate the clinical application and therapeutic efficacy of Suzi Jiangqi Decoction combined with Sanzi Yangqin Decoction in the treatment of COPD, with a particular focus on its role in managing phlegm-damp obstruction of the lungs. Methods: A comprehensive review of recent clinical studies and experimental data was conducted to assess the therapeutic effects of Suzi Jiangqi Decoction and Sanzi Yangqin Decoction in COPD management. The analysis focused on their impact on pulmonary function, symptom relief, and potential mechanisms of action. Results: Clinical trials have shown that this combined prescription can significantly alleviate symptoms such as cough, wheezing, and shortness of breath in patients with COPD, while also improving pulmonary function indicators, with fewer adverse reactions. In addition, the combination therapy can enhance patients’ quality of life and improve respiratory health status. Conclusion: The combination of Suzi Jiangqi Decoction and Sanzi Yangqin Decoction demonstrates promising clinical efficacy in the treatment of COPD, particularly for phlegm-damp obstruction of the lungs. Current evidence supports its therapeutic benefits in improving lung function and alleviating symptoms, potentially offering advantages over conventional treatments. However, further large-scale, randomized controlled trials (RCTs) are essential to validate its long-term safety and effectiveness.

Advances in Clinical MedicineVol. 15(05)
Zero hunger
Openalex Percentile: Top 82%
Chronic Obstructive Pulmonary Disease (COPD) Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Research Progress on the Treatment of COPD with Suzi Jiangqi Decoction Combined with Sanzi Yangqin Decoction — 健航 任 · Advances in Clinical Medicine (2025) | TGRS Research Map | TGRS